<p>Values indicate the median (interquartile range). DM: dermatomyositis; IP: interstitial pneumonia; CADM: clinically amyopathic DM; RPIP: rapid progressive IP; Disease duration: disease duration from onset of respiratory symptoms of IP to initiation of treatments; MDA5: anti-melanoma differentiation-associated gene 5; Ab: antibody; ARS: aminoacyl-tRNA synthetase; CK: creatine kinase; LD: lactate dehydrogenase; CRP: C-reactive protein; AaDO<sub>2</sub>: alveolar-arterial oxygen difference; VC: vital capacity; Dlco: diffusion capacity of the lung for carbon monoxide; GGO: ground-glass opacity; PSL: prednisolone; CSA: cyclosporine; TAC: tacrolimus; IVCY: intravenous pulse cyclophosphamide.</p><p><sup>a</sup>n = 13.</p><p><sup>b</sup>n = 7.</...
Rationale: As the initial treatment of rapidly progressive interstitial lung disease (RPILD) with an...
A patient with amyopathic dermatomyositis associated with fatal rapidly progressive interstitial pne...
<p>Prevalence of dermatomysitis (DM), clinically amyopathic DM (CADM), polymyositis (PM), PM/DM-over...
<p>DM: dermatomyositis; IP: interstitial pneumonia; RPIP: rapidly progressive IP; CIP: chronic IP; M...
<p>DM: dermatomyositis; IP: interstitial pneumonia; F: female; M: male; CADM: clinically amyopathic ...
<p>Laboratory markers are presented as the median (interquartile range). DM: dermatomyositis; IP: in...
<p>Laboratory markers are presented as the median (interquartile range). DM, dermatomyositis; IP, in...
<p>PM: polymyositis; DM: dermatomyositis; ILD: interstitial lung disease.</p><p>Clinical data for PM...
<p>The serum LIGHT level was higher in the DM-IP patients than in the DM patients and was significan...
<p>Data are presented as the medians (interquartile ranges) or n (%).</p><p>ILD: interstitial lung d...
<p>Data are presented as n (%), median (range).</p><p>*<i>P</i> < 0.05</p><p>ILD, interstitial lung ...
SummaryBackgroundAutoantibodies against aminoacyl-tRNA synthetases (ARS) have been found to be highl...
Kazuhiro Kurasawa,1,2 Satoko Arai2 1Center of Rheumatic Diseases, Dokkyo Medical University, Mibu, T...
<p>Abbreviations: CI, confidence interval, hazard ratio.</p><p><sup>†</sup>p< 0.05,</p><p><sup>‡</su...
Polymyositis (PM) and dermatomyositis (DM) are systemic inflammatory disorders affecting skeletal mu...
Rationale: As the initial treatment of rapidly progressive interstitial lung disease (RPILD) with an...
A patient with amyopathic dermatomyositis associated with fatal rapidly progressive interstitial pne...
<p>Prevalence of dermatomysitis (DM), clinically amyopathic DM (CADM), polymyositis (PM), PM/DM-over...
<p>DM: dermatomyositis; IP: interstitial pneumonia; RPIP: rapidly progressive IP; CIP: chronic IP; M...
<p>DM: dermatomyositis; IP: interstitial pneumonia; F: female; M: male; CADM: clinically amyopathic ...
<p>Laboratory markers are presented as the median (interquartile range). DM: dermatomyositis; IP: in...
<p>Laboratory markers are presented as the median (interquartile range). DM, dermatomyositis; IP, in...
<p>PM: polymyositis; DM: dermatomyositis; ILD: interstitial lung disease.</p><p>Clinical data for PM...
<p>The serum LIGHT level was higher in the DM-IP patients than in the DM patients and was significan...
<p>Data are presented as the medians (interquartile ranges) or n (%).</p><p>ILD: interstitial lung d...
<p>Data are presented as n (%), median (range).</p><p>*<i>P</i> < 0.05</p><p>ILD, interstitial lung ...
SummaryBackgroundAutoantibodies against aminoacyl-tRNA synthetases (ARS) have been found to be highl...
Kazuhiro Kurasawa,1,2 Satoko Arai2 1Center of Rheumatic Diseases, Dokkyo Medical University, Mibu, T...
<p>Abbreviations: CI, confidence interval, hazard ratio.</p><p><sup>†</sup>p< 0.05,</p><p><sup>‡</su...
Polymyositis (PM) and dermatomyositis (DM) are systemic inflammatory disorders affecting skeletal mu...
Rationale: As the initial treatment of rapidly progressive interstitial lung disease (RPILD) with an...
A patient with amyopathic dermatomyositis associated with fatal rapidly progressive interstitial pne...
<p>Prevalence of dermatomysitis (DM), clinically amyopathic DM (CADM), polymyositis (PM), PM/DM-over...